Participated · Series E · May 2026

Garner Health uses one of the nation’s largest medical datasets—covering over 60 billion medical records from 320 million patients—and more than 550 proprietary clinical metrics to measure provider quality and guide member choices. The company has developed an AI-powered Garner Research Agent to continuously integrate medical literature into clinical metrics and a member-facing Garner Assistant to help users find providers, book appointments, and manage benefits and claims. Garner partners with employers, health plans, and providers—nearly 800 customers including USA Today, Paylocity, and the University of Oklahoma—and serves over 2.5 million members. Financially, Garner reports roughly $200 million in gross annual recurring revenue and says revenue has more than doubled for five consecutive years. Its incentive model reduces member out-of-pocket costs (members pay on average 80% less to see top doctors) and yields an average 12% reduction in employer healthcare spend in the first year. The company has also announced partnerships with providers such as Mercy, Atlantic Health, Teladoc, and Marathon Health.

Participated · Series A · Sep 2025

SureCo provides an enrollment and administration platform that lets large employers contribute pre-tax dollars so employees can purchase individual health insurance plans from all major carriers in their area. By shifting from traditional group health plans to ICHRAs, employers gain predictable costs, streamlined compliance, and broader plan choice for workers. The company focuses on enterprises with at least 200 employees and positions itself as a full-service administrator, combining software with an award-winning support team. Growing momentum in the ICHRA market—44% of large employers are evaluating the model for 2026—has accelerated demand for SureCo’s offering. With fresh capital, SureCo plans to deepen carrier integrations, enhance its technology platform, and enlarge its service organization. Based in Santa Ana, California, the company aims to cement its leadership in the large-group ICHRA segment. Specific revenue, customer counts, or other operating metrics were not disclosed in the article.

Participated · Series C · Jun 2025

Arine operates an AI-driven medication optimization platform that delivers scalable, personalized medication therapy recommendations to health plans and risk-bearing providers. The platform leverages large, diverse datasets to identify the right individuals, recommend effective interventions, and continuously measure impact. Arine reports outcomes including >10% total cost savings and >40% reduction in hospitalizations, and it experienced >100% growth last year with average contract expansion of 80% with existing clients. The company focuses on improving medication safety, adherence, and effectiveness across populations, including underserved communities. With new funding, Arine plans to expand specialty pharmacy management, accelerate AI innovation to automate high-volume, low-complexity tasks, and integrate additional data to further personalize medication therapy. Arine is a medication intelligence startup that uses its platform to help health plans reduce medication errors, avoid complications, and keep patients out of the hospital. The company serves health plans and risk-bearing providers by improving medication safety and lowering cost of care. Founded in 2017 and based in San Francisco, Arine provides technology to enable better clinical and financial outcomes around medications. Arine plans to use the new funding to advance its platform capabilities to enable value-based care at scale. It intends to expand offerings beyond health plans and providers to other channel partners across the value-based care continuum. The company raised the financing as a mix of equity and debt to support that product and market expansion. Arine is an AI-driven platform that optimizes medication management for health plans and providers. The platform intakes clinical, social, and behavioral data and uses thousands of algorithms to recommend just-in-time clinical interventions for each patient. Those timely interventions are intended to reduce the total cost of care and drive a significant ROI, and the company states it saves one in every six healthcare dollars spent. Arine currently actively manages 5.5M lives. The company plans to use new funding to rapidly scale its team and its technology platform. Its product enables clinicians to provide personalized care by creating a whole picture of each patient based on multi-source data.

Participated · Series A · May 2025

Clarium builds Astra OS, an AI-powered healthcare supply chain resiliency platform that collects, unifies, and automates crowdsourced data from providers, suppliers, and vendors. The platform predicts supply chain disruptions using real-time weather, geopolitical, and current events data and delivers tailored recommendations for substitutions and disruption resolution. Astra OS spans workflow operations, inventory and stock management, and disruption and substitution optimization, and was developed in collaboration with major health systems. Hospitals adopting Astra OS have seen over $10 million in average cost savings, 50% faster disruption resolution, and 88% substitute approvals. Clarium plans to accelerate Astra OS development with additional apps and solutions, expand its team, and grow relationships with new health system partners. The company has expanded leadership and collaborators since its 2024 seed round and has raised $43 million to date. Clarium builds Astra OS, an AI-powered workflow platform and data ecosystem that unifies real-time supply chain data and delivers workflow applications for hospitals. The platform includes modules such as Disruption Monitor, Substitute Manager, and Card Optimizer to automate inventory management and approvals. Since integrating Astra OS, partners have identified an average of $10M+ in cost savings and productivity gains, including a 50% decrease in disruption resolution time, a 63% decrease in substitute approval time, and a 3.7x growth in clinically validated substitutes approved. Yale New Haven Health reports over 300 users across seven departments actively using the platform. The company was founded in 2020 and is headquartered in New York City. Clarium plans to expand integrations, hire across data science, engineering, sales, product, and customer success, and continue investing in generative AI and large language model technologies to augment its offerings.

Participated · Series C · Sep 2024

Vesta Healthcare operates a virtual care platform that connects patients, family, caregivers, home care agencies, providers, and insurance plans to improve care in the home. Its technology and services span from home-based primary care to passive monitoring and caregiver-enabled clinical workflows. Vesta positions caregivers as an integrated part of the clinical care team to improve outcomes for people with home care needs. The company says it is one of the fastest-growing specialized providers and now serves more than 50,000 people. Vesta recently closed a financing round (Series C) and secured additional debt financing to propel growth. The funding is intended to support continued expansion of its technology and services in the home-care setting. Vesta Healthcare operates a 24/7 clinical provider group and digital health platform centered on its "Homecareist" model, which coordinates in‑home care between patients, paid and unpaid caregivers, and the broader care team. The company delivers telehealth, virtual chronic care management, and remote health monitoring to high‑need, frail senior populations through partnerships with home care agencies, health plans, and providers. Vesta reports that 88% of urgent alerts can be managed and resolved in the home and that its program has driven over a 30% reduction in emergency room visits and hospital admissions. Founded in 2018 and headquartered in New York, Vesta now has a presence in five states and nearly nationwide coverage through its affiliated medical group. The company plans to expand into new geographies, launch new program offerings, broaden partnerships with home care agencies, and take on population health programs and financial risk contracts. The new financing will also fund expansion of Sales, Marketing, Operations, and Technology teams to scale its technology‑enabled caregiver engagement and in‑home clinical programs. Vesta Healthcare (fka HT Health) provides technology and clinical services to support caregivers and link caregiver insights to the rest of the care team. The company proactively identifies needs for additional resources in the home and offers 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to build value-based population health programs emphasizing clinical quality, improved outcomes and personalized engagement. The company is led by CEO Randy Klein and is based in New York City. Vesta closed a $30M Series A to fund growth and plans to use the capital to expand product development, engineering, sales and marketing and to reach new markets.